Researcher Profile

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 107 (Search time: 0.005 seconds).

No. Year Title Type
107 2024

2024Article

Txnip regulates the Oct4-mediated pluripotency circuitry via metabolic changes upon differentiationCellular and Molecular Life Sciences, vol. 81, pp. 142-142SoJung Kwak; Cho Lok Song; Yee Sook Cho; In Pyo Choi; Jae Eun Byun; Haiyoung JungJungwoon Lee
Article
106 2023

2023Patent

유도 자연살해세포의 제조방법 및 그의 용도KR10-2022-0114364 (2022.09.08) / 10-2604208 (2023.11.15)조이숙; 김재윤; 김한섭설빛나
Patent
105 2023

2023Research Project

세포 운명전환 기술 기반 차세대 유도 NK 세포 생산 기술 개발연구책임자 : 조이숙 / 사업기간 : 2023.01.01 ~ 2023.12.31
Research Project
104 2023

2023Article

Multifunctional micro/nanofiber based-dressing patch with healing, orotection, and monitoring capabilities for advanced wound careAdvanced Materials Technologies, vol. 8, pp. 2201765-2201765J H Ha; Jae Yun Kim; D Kim; J Ahn; Y Jeong; J Ko; S Hwang; S Jeon; Y Jung; J Gu, et al.
Article
103 2023

2023Research Project

항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2023.01.01 ~ 2023.12.31
Research Project
102 2023

2023Research Project

유도 슈반전구세포 기반 신개념 신경 재생 원천기술 개발연구책임자 : 조이숙 / 사업기간 : 2023.04.01 ~ 2023.12.31
Research Project
101 2022

2022Patent

자연살해세포의 제조방법 및 그의 용도JP2020516900 (2020.03.23) / 7058728 (2022.04.14)최인표; 김한섭설빛나조이숙
Patent
100 2022

2022Research Project

전분화능 타겟 세포운명전환-특이 RNA 프로세싱 조절 연구연구책임자 : 조이숙 / 사업기간 : 2022.03.01 ~ 2023.02.28
Research Project
99 2022

2022Research Project

세포 운명전환 기술 기반 차세대 유도 NK 세포 생산 기술 개발연구책임자 : 조이숙 / 사업기간 : 2022.01.01 ~ 2022.12.31
Research Project
98 2022

2022Research Project

항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2022.01.01 ~ 2022.12.31
Research Project
97 2021

2021Patent

CAR 유전자가 도입된 NK 세포의 제조방법 및 그의 용도KR10-2020-0037719 (2020.03.27) / 10-2298640 (2021.08.31)조이숙; 김재윤; 김한섭설빛나
Patent
96 2021

2021Patent

면역세포의 제조방법 및 그의 용도KR10-2020-0037718 (2020.03.27) / 10-2298639 (2021.08.31)조이숙; 김재윤; 김한섭설빛나
Patent
95 2021

2021Article

Exploration of alternative splicing events in mesenchymal stem cells from human induced pluripotent stem cellsGenes, vol. 12, no. 5, pp. 737-737Ji Eun Jeong; Binna SeolHan-Seop Kim; Jae Yun Kim; Yee Sook Cho
Article
94 2021

2021Article

Directly reprogrammed natural killer cells for cancer immunotherapyNature Biomedical Engineering, vol. 5, no. 11, pp. 1360-1376Han-Seop Kim; Jae Yun Kim; Binna Seol; Cho-Lok Song; Ji Eun Jeong; Yee Sook Cho
Article
93 2021

2021Research Project

차세대 NK 항암세포치료제 개발을 위한 세포전환-유전자가위 융합기술 개발연구책임자 : 조이숙 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
92 2021

2021Research Project

항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
91 2021

2021Research Project

전분화능 타겟 세포운명전환-특이 RNA 프로세싱 조절 연구연구책임자 : 조이숙 / 사업기간 : 2021.03.01 ~ 2022.02.28
Research Project
90 2021

2021Article

Modeling sialidosis with neural precursor cells derived from patient-derived induced pluripotent stem cellsInternational Journal of Molecular Sciences, vol. 22, no. 9, pp. 4386-4386Binna Seol; Young-Dae Kim; Yee Sook Cho
Article
89 2020

2020Patent

자연살해세포의 제조방법 및 그의 용도KR10-2018-0113308 (2018.09.20) / 10-2167548 (2020.10.13)최인표; 김한섭설빛나조이숙
Patent
88 2020

2020Article

Directly induced human Schwann cell precursors as a valuable source of Schwann cellsStem Cell Research & Therapy, vol. 11, pp. 257-257Han-Seop Kim; Jae Yun Kim; Cho-Lok Song; Ji Eun Jeong; Yee Sook Cho
Article
1 2 3 4 5 6